Biolexis Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 29, 2023
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $10,000,000
Company Info
- Founders
- David Bearss
- Company Description
- Biolexis Therapeutics is a privately held biopharmaceutical company committed to developing novel targeted therapeutics.
- Market
- Clinical-stage drug development
- Location
- American Fork, UT, USA
- Coinvestors
- Clarke Capital Partners